Skip to the page

Data / Form D filings / Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.: Form D filing

Cardio Diagnostics Holdings, Inc., a biotechnology company in Chicago, IL, filed a Form D with the SEC in 2024. The latest, on February 6, 2024, reports $1 million sold of a $1 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
311 W. SUPERIOR STREET, SUITE 444, Chicago, IL, 60645
Phone
(855) 226-9991
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1870144

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 6, 2024New notice$1,000,000$1,000,0007Feb 2, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Warren HosseinionnDirector
James IntraterDirector
Stanley LauDirector
Paul BurtonDirector
Oded LevyDirector
Elisa LuqmanExecutive Officer
Robert PhilibertExecutive Officer, Director
Meeshanthini DoganExecutive Officer, Director

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Feb 5, 2024 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Cardio Diagnostics Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.